PFG Investments LLC Purchases 4,150 Shares of Astera Labs, Inc. $ALAB

PFG Investments LLC raised its position in Astera Labs, Inc. (NASDAQ:ALAB) by 232.5% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 5,935 shares of the company’s stock after acquiring an additional 4,150 shares during the period. PFG Investments LLC’s holdings in Astera Labs were worth $650,000 as of its most recent SEC filing.

A number of other hedge funds also recently modified their holdings of the company. Reflection Asset Management bought a new stake in shares of Astera Labs during the fourth quarter valued at approximately $25,000. Smartleaf Asset Management LLC lifted its position in Astera Labs by 422.2% in the fourth quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock worth $32,000 after purchasing an additional 152 shares during the period. Hilltop National Bank boosted its stake in Astera Labs by 100.0% during the fourth quarter. Hilltop National Bank now owns 200 shares of the company’s stock worth $33,000 after buying an additional 100 shares in the last quarter. Aventura Private Wealth LLC acquired a new stake in Astera Labs during the fourth quarter worth $33,000. Finally, Towarzystwo Funduszy Inwestycyjnych PZU SA bought a new stake in Astera Labs in the 4th quarter valued at $33,000. Institutional investors own 60.47% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on ALAB. Rothschild & Co Redburn started coverage on shares of Astera Labs in a research note on Friday, May 1st. They issued a “neutral” rating and a $153.00 price objective for the company. Needham & Company LLC upped their target price on shares of Astera Labs from $220.00 to $260.00 and gave the company a “buy” rating in a research note on Wednesday, May 6th. Morgan Stanley increased their price target on shares of Astera Labs from $210.00 to $240.00 and gave the stock an “overweight” rating in a research report on Wednesday, May 6th. UBS Group raised their price target on shares of Astera Labs from $205.00 to $400.00 and gave the stock a “neutral” rating in a research note on Monday, June 29th. Finally, Weiss Ratings raised Astera Labs from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, May 21st. Twelve equities research analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the company. According to data from MarketBeat, Astera Labs has a consensus rating of “Moderate Buy” and an average price target of $265.75.

Astera Labs Stock Performance

Astera Labs stock opened at $382.89 on Wednesday. The business’s fifty day moving average is $322.82 and its two-hundred day moving average is $209.73. The firm has a market cap of $65.63 billion, a P/E ratio of 258.71, a P/E/G ratio of 4.97 and a beta of 3.66. Astera Labs, Inc. has a 52 week low of $88.18 and a 52 week high of $499.48.

Astera Labs (NASDAQ:ALAB) last announced its earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share for the quarter, beating analysts’ consensus estimates of $0.54 by $0.07. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The company had revenue of $308.36 million during the quarter, compared to analyst estimates of $292.19 million. During the same period last year, the company posted $0.33 earnings per share. The firm’s quarterly revenue was up 93.5% compared to the same quarter last year. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. On average, equities research analysts predict that Astera Labs, Inc. will post 1.84 earnings per share for the current year.

Insider Transactions at Astera Labs

In other news, Director Stefan A. Dyckerhoff sold 3,505 shares of the company’s stock in a transaction that occurred on Wednesday, July 1st. The shares were sold at an average price of $450.00, for a total transaction of $1,577,250.00. Following the transaction, the director directly owned 57,466 shares in the company, valued at approximately $25,859,700. This represents a 5.75% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Manuel Alba sold 8,491 shares of the stock in a transaction that occurred on Wednesday, July 1st. The shares were sold at an average price of $458.38, for a total transaction of $3,892,104.58. Following the sale, the director directly owned 286,863 shares in the company, valued at $131,492,261.94. This trade represents a 2.87% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders have sold 2,164,441 shares of company stock worth $526,198,280. Corporate insiders own 10.40% of the company’s stock.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.